Anti-Human DDR1 Therapeutic Antibody | 708-TAB-179MZ-S(P)
Target DDR1
Clonality Polyclonal
Target Modification Tyr513
Modification Phosphorylation
Reactivity Human, Mouse, Rat
Tested Applications ELISA, WB, IHC
Host Rabbit
Recommended dilutions WB: 1/500 - 1/3000, IHC: 1/50 - 1/100, ELISA: 1/10000. Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Immunogen The antiserum was produced against synthesized phosphopeptide derived from human DDR1 around the
phosphorylation site of tyrosine 513 (P-A-YP-R-L).
Isotype IgG
Form Liquid
Purification Purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC Q08345 (UniProt, ExPASy)
Enzyme Commission Number EC 2.7.1.112 EC 2.7.10.1
Sequence CLLSNPAYRLLLAT
Buffer PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02% sodium azide, 50% glycerol.
Concentration 1 mg/ml
Availability Shipped within 5-10 working days.
Note This product is for research use only.